ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Nicholas Investment Partners, LP's Holding History (CIK: 0001389574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,165,000 Value ($000) $4,654 Avg Close — Range —
Q3 2025
Shares 3,165,000 Value ($000) $5,202 Avg Close — Range —
Q2 2025
Shares 3,250,000 Value ($000) $4,222 Avg Close — Range —
Q4 2023
Shares 1,075,000 Value ($000) $1,056 Avg Close — Range —
Q3 2023
Shares 1,075,000 Value ($000) $992 Avg Close — Range —